Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of CCR9 activity

Inhibitors of CCR9 activity

US Patent 7759390 · Granted Jul 20, 2010

Estimated economic value: $11,137,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-IL12Rβ1 antibodies and their use in treating autoimmune and inflammatory di2015
Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory2015
Therapeutic antibodies binding IL12Rβ12014
Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory2013
Therapeutic binding molecules2010
3,4-dihydro-benzo[e][1,3]oxazin-2-ones2010
N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors2010
N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors2010
N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors2010
N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors2010
N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors2010
Human monoclonal antibodies against human IL-42010